Encompass Health Debt to Equity Ratio 2012-2026 | EHC
Current and historical debt to equity ratio values for Encompass Health (EHC) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Encompass Health debt/equity for the three months ending June 30, 2026 was 0.76.
| Encompass Health Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2026-06-30 | $4.05B | $3.40B | 1.19 |
| 2026-03-31 | $4.01B | $3.31B | 1.21 |
| 2025-12-31 | $3.87B | $3.22B | 1.20 |
| 2025-09-30 | $3.73B | $3.13B | 1.19 |
| 2025-06-30 | $3.75B | $3.03B | 1.24 |
| 2025-03-31 | $3.76B | $2.88B | 1.31 |
| 2024-12-31 | $3.74B | $2.79B | 1.34 |
| 2024-09-30 | $3.79B | $2.67B | 1.42 |
| 2024-06-30 | $3.91B | $2.48B | 1.58 |
| 2024-03-31 | $3.87B | $2.36B | 1.64 |
| 2023-12-31 | $3.85B | $2.26B | 1.71 |
| 2023-09-30 | $3.82B | $2.15B | 1.78 |
| 2023-06-30 | $3.84B | $2.02B | 1.91 |
| 2023-03-31 | $3.82B | $1.93B | 1.99 |
| 2022-12-31 | $3.81B | $1.83B | 2.09 |
| 2022-09-30 | $3.77B | $1.71B | 2.20 |
| 2022-06-30 | $4.58B | $2.50B | 1.83 |
| 2022-03-31 | $4.50B | $2.45B | 1.84 |
| 2021-12-31 | $4.51B | $2.36B | 1.91 |
| 2021-09-30 | $4.46B | $2.26B | 1.97 |
| 2021-06-30 | $4.44B | $2.18B | 2.04 |
| 2021-03-31 | $4.50B | $2.04B | 2.20 |
| 2020-12-31 | $4.48B | $1.97B | 2.27 |
| 2020-09-30 | $4.72B | $1.90B | 2.49 |
| 2020-06-30 | $4.67B | $1.83B | 2.55 |
| 2020-03-31 | $4.34B | $1.80B | 2.42 |
| 2019-12-31 | $4.39B | $1.69B | 2.59 |
| 2019-09-30 | $4.72B | $1.67B | 2.82 |
| 2019-06-30 | $4.23B | $1.58B | 2.67 |
| 2019-03-31 | $3.97B | $1.62B | 2.45 |
| 2018-12-31 | $3.62B | $1.56B | 2.32 |
| 2018-09-30 | $3.55B | $1.58B | 2.24 |
| 2018-06-30 | $3.59B | $1.50B | 2.39 |
| 2018-03-31 | $3.50B | $1.44B | 2.43 |
| 2017-12-31 | $3.47B | $1.40B | 2.49 |
| 2017-09-30 | $3.51B | $1.37B | 2.56 |
| 2017-06-30 | $3.52B | $1.32B | 2.66 |
| 2017-03-31 | $3.73B | $0.98B | 3.80 |
| 2016-12-31 | $3.75B | $0.93B | 4.04 |
| 2016-09-30 | $3.72B | $0.91B | 4.07 |
| 2016-06-30 | $3.78B | $0.85B | 4.45 |
| 2016-03-31 | $3.78B | $0.82B | 4.59 |
| 2015-12-31 | $3.83B | $0.78B | 4.91 |
| 2015-09-30 | $3.46B | $0.79B | 4.38 |
| 2015-06-30 | $2.71B | $0.77B | 3.54 |
| 2015-03-31 | $2.94B | $0.64B | 4.59 |
| 2014-12-31 | $2.77B | $0.62B | 4.47 |
| 2014-09-30 | $2.20B | $0.59B | 3.71 |
| 2014-06-30 | $2.02B | $0.56B | 3.64 |
| 2014-03-31 | $2.06B | $0.48B | 4.27 |
| 2013-12-31 | $2.07B | $0.47B | 4.41 |
| 2013-09-30 | $2.12B | $0.44B | 4.78 |
| 2013-06-30 | $2.12B | $0.39B | 5.40 |
| 2013-03-31 | $2.17B | $0.22B | 9.70 |
| 2012-12-31 | $2.02B | $0.40B | 5.01 |
| 2012-09-30 | $2.10B | $0.36B | 5.90 |
| 2012-06-30 | $2.02B | $0.29B | 6.89 |
| 2012-03-31 | $2.06B | $0.24B | 8.73 |
| 2011-12-31 | $2.07B | $0.20B | 10.27 |
| 2011-09-30 | $2.12B | $0.15B | 13.96 |
| 2011-06-30 | $2.28B | $0.10B | 23.61 |
| 2011-03-31 | $2.41B | $0.07B | 33.32 |
| 2010-12-31 | $2.37B | $0.00B | -1079.23 |
| 2010-09-30 | $2.58B | $-0.78B | -3.30 |
| 2010-06-30 | $2.57B | $-0.82B | -3.15 |
| 2010-03-31 | $2.58B | $-0.86B | -2.99 |
| 2009-12-31 | $2.58B | $-0.90B | -2.87 |
| 2009-09-30 | $2.68B | $-0.92B | -2.90 |
| 2009-06-30 | $2.94B | $-1.05B | -2.80 |
| 2009-03-31 | $2.97B | $-1.04B | -2.84 |
| 2008-12-31 | $3.09B | $-1.09B | -2.84 |
| 2008-09-30 | $3.33B | $-1.35B | -2.47 |
| 2008-06-30 | $3.31B | $-1.35B | -2.46 |
| 2008-03-31 | $3.55B | $-1.54B | -2.31 |
| 2007-12-31 | $3.61B | $-1.56B | -2.32 |
| 2007-09-30 | $4.03B | $-1.51B | -2.68 |
| 2007-06-30 | $4.19B | $-1.79B | -2.34 |
| 2007-03-31 | $5.49B | $-2.25B | -2.44 |
| 2006-12-31 | $5.55B | $-2.19B | -2.54 |
| 2006-09-30 | $5.38B | $-2.10B | -2.57 |
| 2006-06-30 | $5.33B | $-2.02B | -2.64 |
| 2006-03-31 | $5.43B | $-1.97B | -2.75 |
| 2005-12-31 | $5.13B | $-1.54B | -3.33 |
| 2005-09-30 | $0.00B | 0.00 | |
| 2005-06-30 | $0.00B | 0.00 | |
| 2005-03-31 | $0.00B | 0.00 | |
| 2002-12-31 | $5.06B | $-0.53B | -9.57 |
| 2002-09-30 | $3.97B | $3.96B | 1.00 |
| 2002-06-30 | $4.20B | $3.93B | 1.07 |
| 2002-03-31 | $3.82B | $3.91B | 0.98 |
| 2001-12-31 | $4.69B | $-0.11B | -42.06 |
| 2001-09-30 | $3.66B | $3.72B | 0.98 |
| 2001-06-30 | $3.64B | $3.61B | 1.01 |
| 2001-03-31 | $3.84B | $3.62B | 1.06 |
| 2000-12-31 | $4.70B | $0.04B | 131.70 |
| 2000-09-30 | $3.78B | $3.40B | 1.11 |
| 2000-06-30 | $3.79B | $3.33B | 1.14 |
| 2000-03-31 | $3.67B | $3.27B | 1.12 |
| 1999-12-31 | $3.63B | $3.21B | 1.13 |
| 1999-09-30 | $3.72B | $3.41B | 1.09 |
| 1999-06-30 | $3.51B | $3.56B | 0.99 |
| 1999-03-31 | $3.37B | $3.45B | 0.98 |
| 1998-12-31 | $2.28B | $3.29B | 0.69 |
| 1998-09-30 | $3.42B | $3.64B | 0.94 |
| 1998-06-30 | $2.64B | $3.47B | 0.76 |
| 1998-03-31 | $2.47B | $3.32B | 0.74 |
| 1997-12-31 | $2.24B | $3.16B | 0.71 |
| 1997-09-30 | $2.31B | $1.94B | 1.19 |
| 1997-06-30 | $2.05B | $1.85B | 1.11 |
| 1997-03-31 | $2.06B | $1.65B | 1.25 |
| 1996-12-31 | $1.86B | $1.52B | 1.22 |
| 1996-09-30 | $1.79B | $1.40B | 1.28 |
| 1996-06-30 | $1.80B | $1.29B | 1.39 |
| 1996-03-31 | $1.77B | $1.23B | 1.44 |
| 1995-12-31 | $1.75B | $1.19B | 1.47 |
| 1995-09-30 | $1.60B | $0.55B | 2.93 |
| 1995-06-30 | $1.55B | $0.52B | 2.98 |
| 1995-03-31 | $1.14B | $0.45B | 2.52 |
| 1994-12-31 | $0.93B | $0.35B | 2.64 |
| 1994-09-30 | $1.00B | $0.35B | 2.87 |
| 1994-06-30 | $0.95B | $0.33B | 2.89 |
| 1994-03-31 | $0.93B | $0.31B | 2.96 |
| 1993-12-31 | $0.87B | $0.30B | 2.96 |
| 1993-09-30 | $0.43B | $0.32B | 1.37 |
| 1993-06-30 | $0.41B | $0.31B | 1.32 |
| 1993-03-31 | $0.38B | $0.30B | 1.28 |
| 1992-12-31 | $0.35B | $0.29B | 1.22 |
| 1992-09-30 | $0.30B | $0.29B | 1.04 |
| 1992-06-30 | $0.28B | $0.28B | 0.99 |
| 1992-03-31 | $0.26B | $0.28B | 0.93 |
| 1991-12-31 | $0.19B | $0.27B | 0.71 |
| 1991-09-30 | $0.15B | $0.27B | 0.55 |
| 1991-06-30 | $0.12B | $0.26B | 0.45 |
| 1991-03-31 | $0.18B | $0.13B | 1.37 |
| 1990-12-31 | $0.17B | $0.13B | 1.36 |
| 1990-09-30 | $0.16B | $0.13B | 1.31 |
| 1990-06-30 | $0.17B | $0.07B | 2.28 |
| 1990-03-31 | $0.16B | $0.07B | 2.32 |
| 1989-12-31 | $0.15B | $0.07B | 2.30 |
| 1989-09-30 | $0.12B | $0.06B | 1.81 |
| 1989-06-30 | $0.11B | $0.06B | 1.76 |
| 1989-03-31 | $0.08B | $0.06B | 1.38 |
| 1988-12-31 | $0.08B | $0.06B | 1.34 |
| 1988-09-30 | $0.07B | $0.06B | 1.22 |
| 1988-06-30 | $0.06B | $0.05B | 1.11 |
| 1988-03-31 | $0.04B | $0.05B | 0.84 |
| 1987-12-31 | $0.05B | $0.05B | 0.90 |
| 1987-09-30 | $0.03B | $0.05B | 0.62 |
| 1987-06-30 | $0.03B | $0.05B | 0.56 |
| 1987-03-31 | $0.03B | $0.03B | 1.01 |
| 1986-12-31 | $0.03B | $0.03B | 0.99 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $12.036B | $5.935B |
| Encompass Health Corporation is a provider of integrated healthcare services. It offers both facility-based and home-based patient care through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The company delivers high-quality, cost-effective, integrated care in the healthcare space. It provides a continuum of facility-based and home-based post-acute services for its patients and their families, which will gain more prevalence as coordinated care and integrated delivery payment models, such as accountable care organizations and bundled payment arrangements. The company operates through two segments: Inpatient Rehabilitation as well as Home Health and Hospice business. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.581B | 13.26 |
| Quest Diagnostics (DGX) | United States | $27.271B | 23.22 |
| DaVita (DVA) | United States | $12.179B | 14.91 |
| Elanco Animal Health (ELAN) | United States | $11.491B | 21.70 |
| Chemed (CHE) | United States | $6.620B | 23.60 |
| RadNet (RDNT) | United States | $6.069B | 175.27 |
| LifeStance Health (LFST) | United States | $4.991B | 100.46 |
| Option Care Health (OPCH) | United States | $3.523B | 14.89 |
| Aveanna Healthcare Holdings (AVAH) | United States | $3.123B | 21.68 |
| Addus HomeCare (ADUS) | United States | $2.164B | 19.57 |
| Astrana Health (ASTH) | United States | $2.138B | 22.69 |
| Pennant (PNTG) | United States | $1.396B | 36.34 |
| U.S Physical Therapy (USPH) | United States | $1.220B | 32.19 |
| Daxor (DXR) | United States | $0.065B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.024B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |